SKI Market

Indian Indices

Sensex

85,307.45 632.37
( 0.75%)

Global Indices

Nasdaq

48,381.01 -101.93
(-0.21%)

Dow Jones

6,916.41 -10.33
(-0.15%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,948.02 81.49
(0.83%)

Forex

USD-INR

89.89 0.08
(0.09%)

EUR-INR

105.79 0.08
(0.08%)

GBP-INR

121.32 0.14
(0.12%)

JPY-INR

0.58 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Unihealth Hospitals Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

91654

INE0PRF01011

44.0756539

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

UNIHEALTH

189.87

444.38

EPS(TTM)

Face Value()

Div & Yield %

1.51

Back

Marksans Pharma receives USFDA approval for Loperamide Hydrochloride tablets

Nov 19,2025

Marksans Pharma announced USFDA final approval of the Company's wholly owned subsidiary Marksans Pharma Inc.'s Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride Tablets USP, 2 mg (OTC). This product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2mg, of Kenvue Brands LLC (Kenvue) NDA - 019860.

Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea.

85,307.45 632.37 ( 0.75%)

48,381.01 -101.93 (-0.21%)

6,916.41 -10.33 (-0.15%)

50,384.39 -142.53 (-0.28%)

9,948.02 81.49 (0.83%)

89.89 0.08 (0.09%)

105.79 0.08 (0.08%)

121.32 0.14 (0.12%)

0.58 0.00 (0.34%)